Source: International Multiple Sclerosis Management Practice (Imsmp) Vimeo Channel

International Multiple Sclerosis Management Practice (Imsmp) posted a video "Dr. Saud A. Sadiq & the Tisch MSRCNY Stem Cell Trial for MS" on VIMEO

Dr. Saud A. Sadiq discusses the Tisch MSRCNY stem cell trial for MS and details about Phase II. How is it different from HSCT? What do we hope for the future?Cast: IMSMP MSRCNYTags: multiple sclerosis, myelin repair, MS and stem cells

See Video »
International Multiple Sclerosis Management Practice (Imsmp)'s Competitors | International Multiple Sclerosis Management Practice (Imsmp)'s News | International Multiple Sclerosis Management Practice (Imsmp)'s Financials
Stay up-to-date with the latest news on International Multiple Sclerosis Management Practice (Imsmp)
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
CEO Avatar

CEO

Update CEO

CEO Approval Rating

- -/100

Read more
Stay up-to-date with the latest news on International Multiple Sclerosis Management Practice (Imsmp)